Skip to main content
Premium Trial:

Request an Annual Quote

Getting Closer, But Work Remains

Premium

While progress is being made toward the goal of personalized medicine for cancer patients, much work remains, writes Rachael Rettner at MyHealthNewsDaily. "We're much better than we were a decade ago" at tailoring patients' treatments, Monter Cancer Center's Daniel Budman tells Rettner. Much of this progress is being fueled by advances in genome sequencing — which is falling quickly in price — as sequencing can be used to find the mutations in a particular patient's tumor. Marc Symons from the Feinstein Institute for Medical Research adds that the main hurdle is determining which mutations affect the course of the disease and finding drugs that target those mutations.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.